Using Ketamine for Depression

October 5, 2012
By

In any given year, 7% of adults suffer from major depression, and at least 1 in 10 youth will reckon with the disorder at some point during their teenage years. But about 20% of these cases will not respond to current treatments; for those that do, relief may take weeks to months to come.

There is one treatment, however, that works much faster: the anesthetic and “club drug” ketamine. It takes effect within hours. A single dose of ketamine produces relief of depression that has been shown in studies to last for up to 10 days; it also appears to reduce symptoms of bipolar disorder and suicidal thoughts.  Now, a new research review published in Science calls the discovery of these effects of ketamine, “arguably the most important discovery in half a century” of depression research.

Ketamine doesn’t work the way traditional antidepressants do. Many such drugs affect levels of the neurotransmitter serotonin in the brain, and while the idea that depression is caused by low levels of serotonin or an “imbalance” of other key neurotransmitters has been firmly fixed in the popular imagination, scientists have known for decades that it cannot be that simple. For one, antidepressant drugs change the brain’s neurotransmitter levels immediately, yet depression doesn’t lift for several weeks, a delay that could be potentially deadly.

At first, ketamine seemed to throw a monkey wrench into that neat idea, however. It didn’t seem likely that a drug could repair cells within hours, but new research explored in a review paper in the journal Science suggests just that. Ketamine rapidly spurs the growth of new synapses, the connections between brain cells, and is associated with “reversal of the atrophy caused by chronic stress,” the authors write.

Unfortunately, the hallucinogenic and often outright unpleasant effects of ketamine mean that it can’t be used in the same way typical antidepressants are, and fears about its potential for misuse also hamper its development. Researchers are frantically trying to develop compounds that have the same effects as ketamine without producing a “high.”

In the meanwhile, however, ketamine is already FDA approved, so there’s nothing stopping psychiatrists from trying it and patients from asking for access to it in emergency situations when all else has failed. However, it must be given by infusion and carefully monitored (nasal sprays are being developed and there is an oral form that has some effects, but is not optimally absorbed), and the drug impairs patients for hours. Still, it relieves depression for at least several days:  if there’s a choice between being entirely dysfunctional seven days a week or only out of commission for one or two, many people would accept that trade-off.

Read more: Time Healthland

Tags: , , ,

Comments are closed.

Follow The Feminist Wire

Arts & Culture

  • Poem Suite: Shards Rainbow Shards

    In our Poem Suites, we bring together the voices of emerging and established poets exploring a common theme. In today’s Poem Suite, two poets explore fracturing, fragmentation and “shards” from feminist perspectives. . Making Mosaics By Leah Ware Gluing the pieces together, One by one, the mirrors go down Along [...]

  • Poem Suite: Monsters magical-weave-mirror

    In our Poem Suites, we bring together the voices of emerging and established poets exploring a common theme. In today’s Poem Suite, two poets explore images of monsters and monstrosity from feminist perspectives.    Mary Shelley: My Mother’s Monsters By Melissa Knox   By the time I came along she [...]

  • Poem Suite: Becoming DSC_0377

    In our Poem Suites, we bring together the voices of emerging and established poets exploring a common theme. In today’s Poem Suite, two poets explore processes of change, motion, and becoming from feminist perspectives.        From “Lesion” By Indrani Sengupta   thereafter   overgrown freckle. overzealous lovemark not [...]